Seres Therapeutics (MCRB)
(Delayed Data from NSDQ)
$1.03 USD
+0.28 (37.44%)
Updated May 9, 2024 04:00 PM ET
After-Market: $1.08 +0.05 (4.85%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Seres Therapeutics (MCRB) reported earnings of -$0.27 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 25.00%. Look out for MCRB's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year decrease of 197.22%.
Earnings History
Price & Consensus
Zacks News for MCRB
Seres Therapeutics (MCRB) Misses Q2 Earnings Estimates
MCRB: What are Zacks experts saying now?
Zacks Private Portfolio Services